186 related articles for article (PubMed ID: 7229976)
41. Pharmacokinetics of netilmicin during hemodialysis: comparison of four artificial kidneys.
Herrero A; Rius Alarcó F; García-Díez JM; Mahiques E; Domingo JV
Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):605-9. PubMed ID: 3209278
[TBL] [Abstract][Full Text] [Related]
42. Citrate kinetics in patients receiving long-term hemodialysis therapy.
Bauer E; Derfler K; Joukhadar C; Druml W
Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
[TBL] [Abstract][Full Text] [Related]
43. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
Schmidt P; Korn A; Hitzenberger G; Zazgornik J; Kopsa H; Pils P
Wien Med Wochenschr; 1980 Feb; 130(4):171-3. PubMed ID: 7376686
[TBL] [Abstract][Full Text] [Related]
44. Removal of phenytoin by hemodialysis in uremic patients.
Martin E; Gambertoglio JG; Adler DS; Tozer TN; Roman LA; Grausz H
JAMA; 1977 Oct; 238(16):1750-3. PubMed ID: 578272
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
[TBL] [Abstract][Full Text] [Related]
46. Hemodialyzability of sertraline.
Schwenk MH; Verga MA; Wagner JD
Clin Nephrol; 1995 Aug; 44(2):121-4. PubMed ID: 8529300
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis.
Shah PM; Knobloch M; Haag R; Kühnle HF
Methods Find Exp Clin Pharmacol; 1982; 4(3):185-8. PubMed ID: 6289027
[TBL] [Abstract][Full Text] [Related]
48. Cefamandole kinetics in uremic patients undergoing hemodialysis.
Gambertoglio JG; Aziz NS; Lin ET; Grausz H; Naughton JL; Benet LZ
Clin Pharmacol Ther; 1979 Nov; 26(5):592-9. PubMed ID: 498702
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
[TBL] [Abstract][Full Text] [Related]
50. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
[TBL] [Abstract][Full Text] [Related]
51. The pharmacokinetics of dihydroxypropyltheophylline: a basis for rational therapy.
Simons FE; Simons KJ; Bierman CW
J Allergy Clin Immunol; 1975 Nov; 56(5):347-55. PubMed ID: 1181352
[TBL] [Abstract][Full Text] [Related]
52. Profound mishandling of protein glycation degradation products in uremia and dialysis.
Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
[TBL] [Abstract][Full Text] [Related]
53. Elimination and clearance of pamidronate by haemodialysis.
Buttazzoni M; Rosa Diez GJ; Jager V; Crucelegui MS; Algranati SL; Plantalech L
Nephrology (Carlton); 2006 Jun; 11(3):197-200. PubMed ID: 16756631
[TBL] [Abstract][Full Text] [Related]
54. Pyrazinamide and pyrazinoic acid pharmacokinetics in patients with chronic renal failure.
Stamatakis G; Montes C; Trouvin JH; Farinotti R; Fessi H; Kenouch S; Méry JP
Clin Nephrol; 1988 Oct; 30(4):230-4. PubMed ID: 3214968
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
56. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
57. Effect of tetracycline hydrochloride on theophylline kinetics.
Mathis JW; Prince RA; Weinberger MM; McElnay JC
Clin Pharm; 1982; 1(5):446-8. PubMed ID: 7184676
[TBL] [Abstract][Full Text] [Related]
58. Influence of type of dialyzer on the pharmacokinetics of amikacin.
Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
[TBL] [Abstract][Full Text] [Related]
59. Effects of hemodialysis on theophylline kinetics.
Anderson JR; Poklis A; McQueen RC; Purtell JN; Slavin RG
J Clin Pharmacol; 1983 Oct; 23(10):428-32. PubMed ID: 6643695
[TBL] [Abstract][Full Text] [Related]
60. Long-term short hemodialysis-implications to dialysis index.
Raja RM; Kramer MS; Rosenbaum JL
Trans Am Soc Artif Intern Organs; 1978; 24():367-75. PubMed ID: 102059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
